Oncology research has always been a passion of mine. Throughout my undergraduate study at Penn State, I made a point of exploring the full spectrum of biomedical research, from basic gene regulation work to clinical studies of chemotherapeutic toxicity. While I began in wet-bench basic and translational science, intending to work as close to the fundamental mechanisms of cancer as possible, I ultimately found that I preferred the research methodology and the universal applicability of epidemiology and biostatistics. To me, cancer risk prediction and risk stratification is the ideal fusion of genetics, clinical significance, and statistical methodology, allowing me to utilize my broad skillset to assist patients through cancer prevention, when interventions are by far the most effective. My ultimate goal is to become a physician-scientist with a specialty in oncology and a research focus on cancer epidemiology. To me, a PhD in Cambridge’s Department of Public Health and Primary Care is the perfect complement to my medical ambitions, allowing me to integrate my research directly into the clinic and help inform patient treatment around the world.